12/23
08:00 am
atrc
AtriCure to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
Medium
Report
AtriCure to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
12/17
08:14 am
atrc
AtriCure, Inc. (NASDAQ: ATRC) had its "overweight" rating re-affirmed by analysts at JPMorgan Chase & Co.. They now have a $40.00 price target on the stock.
Low
Report
AtriCure, Inc. (NASDAQ: ATRC) had its "overweight" rating re-affirmed by analysts at JPMorgan Chase & Co.. They now have a $40.00 price target on the stock.
12/9
11:49 am
atrc
AtriCure, Inc. (NASDAQ: ATRC) had its price target raised by analysts at Canaccord Genuity Group Inc. from $53.00 to $61.00. They now have a "buy" rating on the stock.
Low
Report
AtriCure, Inc. (NASDAQ: ATRC) had its price target raised by analysts at Canaccord Genuity Group Inc. from $53.00 to $61.00. They now have a "buy" rating on the stock.
11/28
07:58 am
atrc
AtriCure, Inc. (NASDAQ:ATRC) Shares Could Be 26% Below Their Intrinsic Value Estimate [Yahoo! Finance]
Low
Report
AtriCure, Inc. (NASDAQ:ATRC) Shares Could Be 26% Below Their Intrinsic Value Estimate [Yahoo! Finance]
11/20
08:00 am
atrc
AtriCure to Participate in the Piper Sandler 36th Annual Healthcare Conference
Low
Report
AtriCure to Participate in the Piper Sandler 36th Annual Healthcare Conference
11/7
08:00 am
atrc
AtriCure to Participate in the Stifel 2024 Healthcare Conference
Low
Report
AtriCure to Participate in the Stifel 2024 Healthcare Conference
11/1
08:17 am
atrc
US$42.67 - That's What Analysts Think AtriCure, Inc. (NASDAQ:ATRC) Is Worth After These Results [Yahoo! Finance]
Medium
Report
US$42.67 - That's What Analysts Think AtriCure, Inc. (NASDAQ:ATRC) Is Worth After These Results [Yahoo! Finance]
10/30
02:16 pm
atrc
AtriCure, Inc. (NASDAQ: ATRC) had its price target raised by analysts at Canaccord Genuity Group Inc. from $49.00 to $53.00. They now have a "buy" rating on the stock.
Low
Report
AtriCure, Inc. (NASDAQ: ATRC) had its price target raised by analysts at Canaccord Genuity Group Inc. from $49.00 to $53.00. They now have a "buy" rating on the stock.
10/30
12:21 pm
atrc
AtriCure, Inc. (NASDAQ: ATRC) had its price target raised by analysts at Oppenheimer Holdings Inc. from $32.00 to $36.00. They now have an "outperform" rating on the stock.
Low
Report
AtriCure, Inc. (NASDAQ: ATRC) had its price target raised by analysts at Oppenheimer Holdings Inc. from $32.00 to $36.00. They now have an "outperform" rating on the stock.
10/30
11:28 am
atrc
AtriCure, Inc. (NASDAQ: ATRC) had its price target raised by analysts at JPMorgan Chase & Co. from $30.00 to $40.00. They now have an "overweight" rating on the stock.
Low
Report
AtriCure, Inc. (NASDAQ: ATRC) had its price target raised by analysts at JPMorgan Chase & Co. from $30.00 to $40.00. They now have an "overweight" rating on the stock.
10/30
10:08 am
atrc
AtriCure, Inc. (NASDAQ: ATRC) had its price target raised by analysts at UBS Group AG from $35.00 to $40.00. They now have a "buy" rating on the stock.
Medium
Report
AtriCure, Inc. (NASDAQ: ATRC) had its price target raised by analysts at UBS Group AG from $35.00 to $40.00. They now have a "buy" rating on the stock.
10/30
08:00 am
atrc
AtriCure, Inc. (NASDAQ: ATRC) had its price target raised by analysts at Needham & Company LLC from $34.00 to $40.00. They now have a "buy" rating on the stock.
Low
Report
AtriCure, Inc. (NASDAQ: ATRC) had its price target raised by analysts at Needham & Company LLC from $34.00 to $40.00. They now have a "buy" rating on the stock.
10/29
11:54 pm
atrc
AtriCure, Inc. (ATRC) Q3 2024 Earnings Call Transcript [Seeking Alpha]
Low
Report
AtriCure, Inc. (ATRC) Q3 2024 Earnings Call Transcript [Seeking Alpha]
10/29
04:01 pm
atrc
AtriCure Reports Third Quarter 2024 Financial Results
High
Report
AtriCure Reports Third Quarter 2024 Financial Results
10/28
08:00 am
atrc
AtriCure to Participate in the UBS Global Healthcare Conference
Low
Report
AtriCure to Participate in the UBS Global Healthcare Conference
10/16
02:11 pm
atrc
AtriCure's Stock Rises After Launch of cryoSPHERE MAX Device [Yahoo! Finance]
Low
Report
AtriCure's Stock Rises After Launch of cryoSPHERE MAX Device [Yahoo! Finance]
10/15
08:00 am
atrc
AtriCure Announces Launch of cryoSPHERE MAX™ Probe for Post-Operative Pain Management
Low
Report
AtriCure Announces Launch of cryoSPHERE MAX™ Probe for Post-Operative Pain Management
10/13
09:49 am
atrc
Shareholders in AtriCure (NASDAQ:ATRC) are in the red if they invested three years ago [Yahoo! Finance]
Low
Report
Shareholders in AtriCure (NASDAQ:ATRC) are in the red if they invested three years ago [Yahoo! Finance]
10/8
08:00 am
atrc
AtriCure to Announce Third Quarter 2024 Financial Results
Medium
Report
AtriCure to Announce Third Quarter 2024 Financial Results